170 related articles for article (PubMed ID: 26176231)
1. CHA2DS2-VASc and R2CHA2DS2-VASc scores have predictive value in patients with acute coronary syndromes.
Kiliszek M; Szpakowicz A; Filipiak KJ; Kołtowski Ł; Południewska D; Szymański F; Peller M; Budnik M; Nargiełło E; Musiał WJ; Kamiński KA; Opolski G
Pol Arch Med Wewn; 2015; 125(7-8):545-52. PubMed ID: 26176231
[TBL] [Abstract][Full Text] [Related]
2. Prediction of acute-coronary-syndrome using newly-defined R
Topaz G; Ben-Zvi E; Pereg D; Kitay-Cohen Y; Benchetrit S; Zitman-Gal T; Lotan S; Cohen-Hagai K
J Cardiol; 2021 Apr; 77(4):370-374. PubMed ID: 32988692
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of the CHA
Peng H; Sun Z; Chen H; Zhang Y; Ding X; Zhao XQ; Li H
Am J Cardiol; 2019 Aug; 124(4):476-484. PubMed ID: 31235063
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of CHADS2 and CHA2DS2-VASc scores for post-discharge outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Ma X; Shao Q; Dong L; Cheng Y; Lv S; Shen H; Liang J; Wang Z; Zhou Y
Medicine (Baltimore); 2020 Jul; 99(30):e21321. PubMed ID: 32791726
[TBL] [Abstract][Full Text] [Related]
5. Mortality prediction with CHA2DS2-VASc, CHA2DS2-VASc-HS and R2CHA2DS2-VASc score in patients hospitalized due to COVID-19.
Katkat F; Karahan S; Varol S; Kalyoncuoglu M; Okuyan E
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6767-6774. PubMed ID: 34787881
[TBL] [Abstract][Full Text] [Related]
6. CHA2DS2-VASc-HS score in non-ST elevation acute coronary syndrome patients: assessment of coronary artery disease severity and complexity and comparison to other scoring systems in the prediction of in-hospital major adverse cardiovascular events.
Taşolar H; Çetin M; Ballı M; Bayramoğlu A; Otlu YÖ; Türkmen S; Aktürk E
Anatol J Cardiol; 2016 Oct; 16(10):742-748. PubMed ID: 27025198
[TBL] [Abstract][Full Text] [Related]
7. Atrial high-rate episodes intensify R
Li YP; Chen JY; Chen TW; Lu WD
Sci Rep; 2023 May; 13(1):7640. PubMed ID: 37169860
[TBL] [Abstract][Full Text] [Related]
8. CHA2DS2-VASc score is useful in predicting poor 12-month outcomes following myocardial infarction in diabetic patients without atrial fibrillation.
Hudzik B; Szkodziński J; Hawranek M; Lekston A; Poloński L; Gąsior M
Acta Diabetol; 2016 Oct; 53(5):807-15. PubMed ID: 27339195
[TBL] [Abstract][Full Text] [Related]
9. Validation of the CHA2DS2-VASc Score in Predicting Coronary Atherosclerotic Burden and In-Hospital Mortality in Patients With Acute Coronary Syndrome.
Kurtul A; Acikgoz SK
Am J Cardiol; 2017 Jul; 120(1):8-14. PubMed ID: 28479165
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of R
Methavigul K; Sairat P; Krittayaphong R;
BMC Cardiovasc Disord; 2021 Nov; 21(1):540. PubMed ID: 34772351
[TBL] [Abstract][Full Text] [Related]
11. CHA2DS2-VASc score and clinical outcomes of patients with acute coronary syndrome.
Rozenbaum Z; Elis A; Shuvy M; Vorobeichik D; Shlomo N; Shlezinger M; Goldenberg I; Kimhi O; Pereg D
Eur J Intern Med; 2016 Dec; 36():57-61. PubMed ID: 27707608
[TBL] [Abstract][Full Text] [Related]
12. CHA2DS2-VASc Score as an Independent Predictor of Suboptimal Reperfusion and Short-Term Mortality after Primary PCI in Patients with Acute ST Segment Elevation Myocardial Infarction.
Ashoori A; Pourhosseini H; Ghodsi S; Salarifar M; Nematipour E; Alidoosti M; Haji-Zeinali AM; Nozari Y; Amirzadegan A; Aghajani H; Jalali A; Hosseini Z; Jenab Y; Geraiely B; Omidi N
Medicina (Kaunas); 2019 Feb; 55(2):. PubMed ID: 30717292
[TBL] [Abstract][Full Text] [Related]
13. Value of Adding the CHA2DS2-VASc Score to the GRACE Score for Mortality Risk Prediction in Patients With Acute Coronary Syndrome.
Shuvy M; Klein E; Cohen T; Shlomo N; Rozenbaum Z; Pereg D
Am J Cardiol; 2019 Jun; 123(11):1751-1756. PubMed ID: 30922543
[TBL] [Abstract][Full Text] [Related]
14. Is the Newly Defined R2CHA2DS2-Vasc Score a Predictor for Late Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement?
Kalyoncuoglu M; Ozturk S
Braz J Cardiovasc Surg; 2020 Apr; 35(2):145-154. PubMed ID: 32369293
[TBL] [Abstract][Full Text] [Related]
15. Mortality prediction using a modified R
Levy D; Gur E; Topaz G; Naser R; Kitay-Cohen Y; Benchetrit S; Sarel E; Cohen-Hagai K; Wand O
Intern Emerg Med; 2022 Sep; 17(6):1711-1717. PubMed ID: 35751741
[TBL] [Abstract][Full Text] [Related]
16. Albuminuria improves R
Piscitelli P; D'Errico MM; Vigna C; Marchese N; Lamacchia O; Fontana A; Copetti M; Pontremoli R; Mirijello A; De Cosmo SA
Nutr Metab Cardiovasc Dis; 2023 Aug; 33(8):1591-1598. PubMed ID: 37263913
[TBL] [Abstract][Full Text] [Related]
17. CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention.
Puurunen MK; Kiviniemi T; Schlitt A; Rubboli A; Dietrich B; Karjalainen P; Nyman K; Niemelä M; Lip GY; Airaksinen KE
Thromb Res; 2014 Apr; 133(4):560-6. PubMed ID: 24461143
[TBL] [Abstract][Full Text] [Related]
18. Predictive Value of CHA2DS2-VASC Score for Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome.
Kurtul A; Yarlioglues M; Duran M
Am J Cardiol; 2017 Mar; 119(6):819-825. PubMed ID: 28040187
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.
Schellings DA; Adiyaman A; Dambrink JE; Gosselink AM; Kedhi E; Roolvink V; Ottervanger JP; Van't Hof AW
Vasc Health Risk Manag; 2016; 12():471-476. PubMed ID: 27920547
[TBL] [Abstract][Full Text] [Related]
20. Comparison of thromboembolic risk scores for evaluating in-hospital events of COVID-19 patients.
Genç Ö; Yildirim A; Genç M; Er F; Alici G; Quisi A; Harbalioğlu H; Allahverdiyev S; Kurt İH
Biomark Med; 2023 Jan; 17(2):59-72. PubMed ID: 37038968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
